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Abstract 
The neurohypophyseal hormones vasopressin and oxytocin were invested, in recent years, with 
novel functions upon striated muscle, regulating its differentiation, trophism, and homeostasis. 
Recent studies highlight that these hormones not only target skeletal muscle but represent novel 
myokines. We discuss the possibility of exploiting the muscle hypertrophying activity of 
oxytocin to revert muscle atrophy, including cancer cachexia muscle wasting. Furthermore, the 
role of oxytocin in cardiac homeostasis and the possible role of cardiac atrophy as a concause of 
death in cachectic patients is discussed. 
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Neurohypophyseal Hormones and Skeletal Muscle 
Homeostasis 
 In the past few decades, the neurohypophyseal 
hormones (NH) vasopressin (AVP) and oxytocin (OT) 
emerged as novel myogenic regulators.1-5  In fact, besides 
their classical roles (uterus, mammary gland, vascular 
smooth muscle, kidney tubules, CNS),2 they were shown 
to target skeletal muscle. OT and AVP are mainly 
produced in the hypothalamus, transported to the 
neurohypophysis, and secreted into circulation. Seven-
transmembrane-domain G-protein-coupled receptors 
(GPCR) and complex downstream signaling processes 
mediate their pleiotropic physiological functions.5 
Functional receptors for NH mediate AVP and OT 
signals in myogenic cells (V1aR in the murine myogenic 
cell line L6, OTR in human satellite cells) and muscle 
fibers.3,6 Interestingly, despite possessing individual 
receptors, AVP and OT have been shown to cross-
activate each other’s receptors.7 
Skeletal muscle is a target of AVP and OT 
In vitro studies indicated that OT and AVP treatments 
dramatically increased the fusion of murine and avian 
myoblasts and human satellite cells.1,2,3 The addition of 
AVP to the culture medium of murine myoblasts induces 
the expression of Myf-5 and myogenin.1 Interaction of 
AVP and the V1a receptor rapidly increases intracellular 
[Ca2+] and stimulates the phospholipases C (PLC), D 
(PLD) and A2 (PLA2), producing intracellular 
messengers such as phosphatidic acid (PA), 
diacylglycerol (DAG) and InsP3 (Figure 1). As shown in 
Figure 1, PA (produced by the PLD-dependent 
hydrolysis of PtdCho) activates PDE4, which in turn 
promotes cAMP breakdown, thus inhibiting cAMP-
dependent activation of PKA, a kinase known to 
negatively regulate myogenic differentiation.9 The 
increase in the intracellular level of Ca2+ interferes with 
the Calcium calmodulin Kinase (CaMK)/Calcineurin 
pathway inducing upregulation of skeletal muscle 
differentiation markers myogenin, MEF2 and GATA2 
(zinc finger proteins) expression.10 The PI3K/Akt/mTOR 
pathway is well known for its role in cell growth, 
proliferation, differentiation, and muscle homeostasis. 
This pathway is recruited in response to NH in myoblasts, 
and its inhibition hampered the AVP-stimulated 
expression of both Akt and mTOR and increased the 
expression of the ubiquitin ligase atrogin-1 and FoxO 
(Figure 1).11 
Satellite cells obtained from aged mice display lower OT 
receptor expression and myogenic potential when 
compared to satellite cells from young animals. By 
treating the “old” and “young” satellite cells with 
exogenous OT or with a selective oxytocin antagonist, 
respectively, OT was demonstrated to be required for 
effective muscle regeneration.12 In vivo, AVP signaling 
accelerates the regeneration of injured skeletal muscle 
and reverts TNF-induced muscle atrophy: 
overexpressing V1aR in the tibialis anterior decreased 
the p-NFkb-p65 protein expression, increased Pax7, 
myogenin and embryonic myosin heavy chain (eMHC) 
expressions after cardiotoxin injury, even in the presence 
of TNF.6 In summary, OT and AVP activate a complex 
array of signaling pathways to regulate skeletal muscle 
homeostasis (modulating different kinases, modifying 
the calcium level, through the CaMK/Calcineurin 
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signaling to activate the myogenic regulatory factors 
expressions, and by stimulating the Akt/mTOR or the 
MAPK pathway to induce muscle cell proliferation, 
differentiation, contraction, and regeneration. 
Skeletal muscle is a source of AVP and OT 
Skeletal muscle is not only a target of neurohypophyseal 
hormones but also a source, acting in this way, as an 
autocrine/paracrine gland for its regulation. OT was 
demonstrated to be expressed by cultured human 
myoblasts.3 De Jager and collaborators revealed that 
cattle administrated continuously with anabolic steroids 
featured an augmented OT mRNA expression in skeletal 
muscle, followed by a ∼ 50-fold higher plasma level of 
OT.13 More recently, C2C12 myogenic cells were shown 
to express and secrete OT in the culture medium at a low 
level under basal conditions.8 These authors 
demonstrated that 17β-estradiol, which stimulates the 
differentiation of these myoblasts, transiently up-
regulates OT gene expression and secretion rapidly after 
treatment. Increased expression of OT in livestock as a 
result of anabolizing treatments was reported by other 
groups.14 Interestingly, the estrogen control of OT 
expression appears to be mediated by ERR, an effect 
which can be further amplified by an OT/OT-R loop.14 
Furthermore, physical activity was shown to 
physiologically stimulate AVP and OT secretion. Several 
groups demonstrated that exercise results in increased 
levels of AVP and OT in the hypothalamus as well as in 
plasma.14 Exercise plays beneficial effects on muscle 
physiology. The exercise-mediated stimulation of AVP 
and OT suggests that physical activity participates in 
their autocrine effect upon skeletal muscle triggering NH 
secretion by muscle and brain, thus regulating their 
receptors and contributing to muscle homeostasis. 
OT, a potential therapeutic agent against muscle atrophy 
Investigations have been conducted in aged mice to 
examine the potential of OT to reverse sarcopenia, which 
involves impaired skeletal muscle regeneration. A 
significant decrease of OT expression in aged mice in 
comparison to young mice has been reported.12 Indeed, a 
low level of OTR on satellite cells accompanies the 
decrease of OT circulating levels in the plasma. 
Moreover, exogenous OT administration in aged mice 
significantly increases muscle regeneration after 
cardiotoxin injury by increasing both the expansion and 
the differentiation of satellite cells through the 
MAPK/ERK pathway.12 Analysis of OT-knock out (KO) 
mice was conducted to better understand the OT role in 
regeneration and sarcopenia. Muscle regeneration was 
 
Fig 1. OT and AVP signaling in skeletal muscle (see acronyms list below). 
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strongly impaired in OT-KO mice. 12-month-old KO 
mice, compared to wild type, displayed premature aging 
with muscle fibrosis and fat infiltration, a pattern 
characteristic of sarcopenia.12 
As in sarcopenia, cancer-cachexia (CC) is characterized 
by muscle wasting, loss of fat and lean mass, and is 
associated with an adverse prognosis. Our group 
demonstrated that physical activity counteracts CC in 
vivo, increasing the survival of tumor-bearing mice and 
counteracting muscle atrophy.15 The effects of CC are 
dependent upon the presence of pro-inflammatory 
cytokines, among these TNF, which has been shown to 
hamper the differentiation potential of myogenic cells, 
ultimately leading to cachexia.16 Since NH have been 
demonstrated to stimulate myogenic differentiation, 
muscle trophism and regeneration, we believe that the 
use of OT may counteract CC-dependent skeletal muscle 
atrophy and thus, ameliorate the quality of life and 
response to treatment of cancer patients. 
Role of Oxytocin in Cardiovascular Regulation 
In the 90s, a group showed that OT is synthesized and 
released also by the heart. They found the concentration 
of OT higher in the atria and in the ventricles than in the 
uterus of rats.17 Furthermore, as in skeletal muscle, OT 
induces cardiomyocytes differentiation in vitro. Its 
addition to the culture medium of P19 cells (mouse 
embryonal carcinoma cells) increased the expression of 
MHC, and cardiac markers DHPR-α1 (dihydropyridine 
receptor α1) and ANP (atrial natriuretic peptide) (Figure 
2). OT up-regulated OTR expression by 5–10%.18 
Later,19 the establishment of the PI3K, Ca-CAMKK and 
AMPK pathways involvement in OT-dependent 
stimulation of glucose uptake was demonstrated (Figure 
2). Therefore, OT contributes to cardiomyogenesis and 
CM differentiation. However, a recent study showed that 
overexpressing OTR specifically in the heart led to a 
decreased motor activity, irregular respiration and death 
because of severe heart failure.20 Indeed, chronic heart 
failure that affects more than 20 millions of people in the 
world, has been reported to induce cachexia. Conversely, 
it is possible to hypothesize that cardiac atrophy takes 
place in cachexia, and that heart failure may play a role 
in cachexia-associated mortality. This suggests a new 
therapeutic approach, using OT to ameliorate the 
cachectic patients’ quality of life and survival. In 
conclusion, OT could be a potential candidate to 
counteract muscle wasting implicated in cachexia. 
List of acronyms 
AKT – Serine-threonine Protein Kinase  
AMPK – AMP-activated Protein Kinase  
ANP - Atrial Natriuretic Peptide 
AVP – Vasopressin 
 
Fig 2. OT signaling in cardiac muscle (see acronyms list below). 
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Ca-CAMKK – Ca2+/Calmodulin-dependent Protein 
Kinase  
CaMK – Calcium Calmodulin Kinase  
cAMP – Cyclic Adenosine Monophosphate 
CC – Cancer Cachexia  
CNS – Central Neural System 
DAG - Diacylglycerol  
DHPR-α1 – Dihydropyridine Receptor α1 
eMHC - embryonic Myosin Heavy Chain 
ERK – Extracellular signal-regulated Kinase 
ERRα – Estrogen-related Receptor α 
FoxO – Forkhead box O  
G – G-protein 
GATA2 – GATA Binding Protein 2 
GPCR - G-protein-coupled receptors  
InsP3 – Inositol Triphosphate  
MAPK – Mitogen-activated Protein Kinase  
MEF – Myocyte Enhancer Factor-2 
MHC – Major Histocompatibility Complex 
mTOR – mammalian Target of Rapamycin 
Myf5 – Myogenic Factor 5 
NH - Neurohypophyseal Hormones 
OT – Oxytocin 
OTR – Oxytocin Receptor 
PA – Phosphatidic Acid 
Pax7 – Paired box protein 7  
PDE4 – Phosphodiesterase-4 
PI3K – Phosphoinositide 3-kinase  
PKA – Protein Kinase A 
p-NFkb – phosphorylated Nuclear Factor-kappa B 
PLA2 – Phospholipases A2 
PLC – Phospholipases C 
PLD – Phospholipases D 
PtdCho – Phosphatidylcholine 
TNF – Tumor Necrosis Factor 
V1aR - Vasopressin Receptor 1a 
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